Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Webinar invite, cardiovascular devices: COVID-19 proved a market share disruptor among the big seven public cardiovascular medtech companies, says GlobalData

On Tuesday, 29 November, 2022, at 11:00 (ET), the Medical Devices team at GlobalData will host a webinar taking a deep dive into historic market revenue trends of cardiovascular medical device companies. Click here to register, and find out: How the seven leading public medical device companies in the cardiovascular devices sector performed during COVID-19 […]
Read more

In vitro diagnostics expands reach to meet pent-up demand for other diseases and better position manufacturers for market volatilities, says GlobalData

Long after the pandemic subsides, countries will find themselves with an increased capacity for in vitro diagnostics (IVD) testing, including clinical-grade genomic sequencing utilized to diagnose complex diseases, such as cancers, says GlobalData. The leading data and analytics company notes that diagnostic tests for metabolic disorders (cholesterol) and other infectious diseases (hepatitis, HIV) will also […]
Read more

NeuroPace’s RNS system may prove to be an essential option to treating idiopathic generalised epilepsy at the source, says GlobalData

Following NeuroPace’s announcement that its first patient has been implanted with its responsive neurostimulation (RNS) system during the ongoing NAUTILUS clinical trials; Aidan Robertson, Medical Analyst at GlobalData, a leading data and analytics company, offers his view: “As the prevalence of epilepsy is increasing, there will be growing demand for non-medicated solutions as the perception […]
Read more

Regulators should address complexities to keep up with AI advancements in medical devices, says GlobalData

Regulatory bodies in the healthcare industry are failing to keep up with the accelerating adoption of artificial intelligence (AI) in medical devices. As many AI technologies have continuous learning capabilities, regulatory bodies such as the FDA and Health Canada should focus on creating a regulatory framework that would allow for ongoing changes, says GlobalData, a […]
Read more

ACE Xtend’s approval will help shorten interventional radiology percutaneous procedure durations, says GlobalData

The recent FDA approval of the ACE Xtend Remote Control Unit will have a positive impact on patients and healthcare personnel as it helps in shortening the durations of interventional percutaneous procedures, says GlobalData, a leading data and analytics company. The XACT ACE Robotic System is a device designed to increase the success of interventional […]
Read more

Automated cath labs to enhance cardiovascular care in India, says GlobalData

GE Healthcare has recently introduced its first made-in-India artificial intelligence (AI) enabled cath lab diagnostic imaging platform, the Optima IGS 320. This sophisticated interventional cardiology system will guide non-invasive cardiovascular procedures with better precision and versatility, says GlobalData, a leading data and analytics company. GlobalData forecasts the Indian cardiovascular devices market to grow at a […]
Read more

AI-enabled made-in-India products to advance patient care in India, says GlobalData

With the rise of artificial intelligence (AI) and machine learning-focused healthtech startups in India, big companies such as Oracle Corp are looking for opportunities to invest and expand their footprint in the country. Against this backdrop, AI-enabled made-in-India products will offer advanced healthcare solutions and improve patient care in India, says GlobalData, a leading data, […]
Read more

New NHMRC Centre to facilitate personalized breast cancer screening in Australia, says GlobalData

The University of Melbourne has recently launched My Breast cancer RISK Centre (MyBRISK), a new National Health and Medical Research Council Centre (NHMRC) for Research Excellence, to apply a holistic risk-based approach to breast cancer screening. This is expected to increase the diagnosis rate and facilitate early cancer detection and personalized screening, thereby reducing the […]
Read more

Automated insulin delivery systems could drive the continuous glucose monitors and insulin pumps market to $20.2 billion by 2030, says GlobalData

For patients with insulin-dependent diabetes, maintaining a healthy blood glucose level can be challenging, says GlobalData. The leading data and analytics company notes that automated insulin delivery (AID) systems, or hybrid closed loop systems, have been developed to make maintaining a healthy glucose level easier. This has led to increased awareness among patients with insulin-dependent […]
Read more

Healthcare firms discover ways to use virtual reality to treat neurological diseases, finds GlobalData

XRHealth, a US-based healthcare platform in the metaverse, has recently published a study that shows the potential of using virtual reality (VR) technologies in upper limb dysfunction in multiple sclerosis patients. With new technologies such as VR and augmented reality (AR) being implemented more often in healthcare industry, companies discover more ways new technologies can […]
Read more

Cloud computing will benefit healthcare industry as it encourages trust and transparency between patients and healthcare providers, says GlobalData

Cloud computing is a growing trend in the healthcare industry, and one that is here to stay, according to GlobalData. The leading data and analytics company notes that this technology not only helps secure patient data but also strengthens transparency between healthcare institutions and their patients. Cloud services will help healthcare companies improve cybersecurity GlobalData’s […]
Read more

Capital expense of orthopedic robots will continually drop due to fierce market competition, says GlobalData

While Intuitive Surgical holds the largest share of the general surgery robotics market, the orthopedic market is more crowded, with manufacturers including Stryker Mako, Zimmer Biomet ROSA RECON, DePuy Synthes VELYS, and Smith & Nephew CORI all battling for dominance, says GlobalData. The leading data and analytics company notes that this has resulted in a […]
Read more

Japan to lead clot management devices market in Asia-Pacific region through 2025, says GlobalData

Owing to the rising geriatric population and subsequently increased burden of cardiovascular diseases, Japan is leading the Asia-Pacific’s clot management devices market and is expected to retain its position through 2025, according to GlobalData, a leading data and analytics company. Ayshi Ganguly, Medical Devices Analyst at GlobalData, comments: “With Japan leading the world’s aging population, […]
Read more

Precision medicine is reshaping cancer care and will help address rising cases, says GlobalData

Precision medicine is reshaping oncology, according to GlobalData, which notes that considering aspects such as a patient’s environment and genetics will provide physicians with a more holistic view of patient requirements. The leading data and analytics company highlights that, since cancer is incredibly variable, the advancement and use of precision medicine is vital in addressing […]
Read more

Valo Health and KSM multi-year partnership could advance personalized medicine with AI and big data, says GlobalData

Following the recent news that Valo Health and Kahn-Sagol-Maccabi (KSM) will perform joint studies using KSM’s Tipa BiobankTM of more than 800,000 samples and Valo’s drug discovery and development platform OpalTM; Ashley Clarke, Medical Analyst at GlobalData, a leading data and analytics company, offers her view: “The collaboration provides an opportunity to utilize the growing […]
Read more
1 … 25 26 27 28 29 … 50